S100B as a potential biomarker for the detection of cytotoxicity of melanocytes

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|23|3|165-171

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.23, Iss.3, 2014-03, pp. : 165-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

S100B Protein Detection in Serum Is a Significant Prognostic Factor in Metastatic Melanoma

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 338-344

Karger

Access to resources Recommend Favorite

S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2093-2103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Elevated Serum Levels of the Chemokine CCL18 in B-Cell Chronic Lymphocytic Leukaemia: Identification of a Novel Biomarker

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-08 ,pp. : 110-114

Karger

Access to resources Recommend Favorite

Clinical significance of serum S100B levels in neurointensive care

By  

Neurocritical Care, Vol. 6, Iss. 2, 2007-04 ,pp. : 94-99

Humana Press, Inc

Access to resources Recommend Favorite

Serum S100B levels in patients with cerebral and extracerebral infectious disease

By Undén Johan   Christensson Bertil   Bellner Johan   Alling Christer   Romner Bertil  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 1, 2004-01 ,pp. : 10-13

Informa Healthcare

Access to resources Recommend Favorite